Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
Clinical Cancer Research (2012)
  • John M. Timmerman, University of California, Los Angeles
  • John C. Byrd, Ohio State University
  • David J. Andorsky, University of California, Los Angeles
  • Reiko E. Yamada, University of California, Los Angeles
  • Janet Kramer, ZymoGenetics
  • Natarajan Muthusamy, Ohio State University
  • Naomi Hunder, ZymoGenetics
  • John M. Pagel, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
October 15, 2012
DOI
10.1158/1078-0432.CCR-12-0456
Citation Information
John M. Timmerman, John C. Byrd, David J. Andorsky, Reiko E. Yamada, et al.. "A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders" Clinical Cancer Research Vol. 18 Iss. 20 (2012) p. 5752 - 5760
Available at: http://works.bepress.com/john-pagel/160/